TriNetX -Platform for Japan Claims Network
Trials that include patients in Japan have an advantage when it comes to regulatory approval in that country, where pharmaceutical sales reached 94B USD in 2020. But approval requires promising results from a well-executed study. Start the process the right way by understanding Japan`s patient population, designing a feasible study, and selecting the right trial sites.
39M Patients
Build your custom cohort from 39 million patients in all eight regions of Japan. Our intuitive query builder makes it easy to group patients by common codes and event dates.
460 Acute Care Hospitals
Patients in our database represent 460 facilities, including 216 with cancer care centers. This breadth ensures representation across patient profiles.
39M Patients
Build your custom cohort from 39 million patients in all eight regions of Japan. Our intuitive query builder makes it easy to group patients by common codes and event dates.
460 Acute Care Hospitals
Patients in our database represent 460 facilities, including 216 with cancer care centers. This breadth ensures representation across patient profiles.